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malaria in Malawian children, J InfecSummary Objectives: Study of the effect of HIV on disease progression in heterogeneous se-
vere malaria syndromes with imprecise diagnostic criteria has led to varying results. Character-
istic retinopathy refines cerebral malaria (CM) diagnosis, enabling more precise exploration of
the hypothesis that HIV decreases the cytokine response in CM, leading to higher parasite den-
sity and a poor outcome.
Methods: We retrospectively reviewed data on clinical progression and laboratory parameters
in 877 retinopathy-positive CM cases admitted 1996e2011 (14.4% HIV-infected) to a large hos-
pital in Malawi. Admission plasma levels of TNF, interleukin-10, and soluble intercellular adhe-
sion molecule (sICAM-1) were measured by ELISA in 135 retinopathy-positive CM cases.
Results: HIV-infected CM cases had lower median plasma levels of TNF (p Z 0.008),Infection and Global Health, UK. Tel.: þ44 (0)151 705 3175, þ44 (0)7928675968 (mobile). Q3
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malaria in Malawian children, J Infecinterleukin-10 (p Z 0.045) and sICAM-1 (p Z 0.04) than HIV-uninfected cases. Although HIV-
infected children were older and more likely to have co-morbidities, HIV-status did not signif-
icantly affect parasite density (p Z 0.90) or outcome (24.8% infected, vs. 18.5% uninfected;
p Z 0.13).
Conclusion: In this well-characterised CM cohort, HIV-coinfection was associated with marked
blunting of the inflammatory response but did not affect parasite density or outcome. These
data highlight the complex influence of HIV on severe malaria and bring into question systemic
inflammation as a primary driver of pathogenesis in human CM.
ª 2016 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).75
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In sub-Saharan Africa over 3 million children are infected
with the Human Immunodeficiency Virus (HIV).1 There are
in excess of 100 million cases of Plasmodium falciparum
infection per year, leading to approximately half a million
deaths, mainly in African children. While the overlap be-
tween the two diseases is considerable, with many malaria
infections occurring in HIV-positive children,2 determining
the effect of HIV on the severity and outcome of malaria
has been problematic, leading to variable and apparently
contradictory results.3e6 Some studies have found
increased parasite density, an association with more severe
malaria and worse outcome, and others have not (See
Table 1 for a summary of published literature). We propose
that at least in part, the use of insufficiently stringent diag-
nostic criteria for cerebral malaria (CM), could have led to
misclassification of cases and therefore variability in the as-
sociations identified.
CM is a prominent severe malaria syndrome defined by
the WHO as unrousable coma (Blantyre Coma Score7 2) in
the presence of P. falciparum parasitaemia, with no other
cause of coma found.8,9 In the absence of additional
criteria this clinical definition leads to over diagnosis of
CM, leaving uncertainty as to whether coma is truly caused
by parasitaemia or whether a person has an uncomplicated
malaria infection and coma due to another aetiology. This is
particularly problematic in high transmission settings where
a high proportion of apparently well children in the commu-
nity are parasitaemic. This was highlighted by a study at our
centre in Malawi where a quarter of children diagnosed as
having WHO-defined CM were found to have a non-malaria
cause of coma and death at autopsy in the context of a pe-
ripheral parasitaemia.9 This mis-classification may be exac-
erbated by HIV co-infection which may increase the risk of
other non-malarial co-morbidities causing coma and thus
confound the ability to detect true associations between
HIV, CM and outcome (e.g. peripheral parasite density,
the inflammatory response or mortality).
Characteristic retinal changes that are indicative of
sequestration of P. falciparum-infected red blood cells
(iRBC) in the neurovasculature10 distinguish with high spec-
ificity and sensitivity those children with histological evi-
dence of CM, from those with a non-malarial coma.9 In
order to re-examine the impact of HIV on CM, we have
therefore used this refined diagnosis to classify a large
cohort of Malawian children with CM, with and without
HIV co-infection. Following the observation that peripheralale EW, et al., HIV coinfection infl
t (2016), http://dx.doi.org/10.10blood mononuclear cells from HIV-infected individuals have
impaired tumour necrosis factor-alpha (TNF) and inter-
leukin 10 (IL-10) production in vitro in response to iRBC
challenge,11 we addressed the specific hypothesis that
HIV-infection results in lower levels of systemic TNF and
IL-10 in CM in vivo and that this is associated with a higher
peripheral parasite density and a higher mortality.Methods
Location
This study was conducted at Queen Elizabeth Central
Hospital (QECH), Blantyre, Malawi. In 2010 HIV prevalence
in pregnant women in this region was 18% and overall sero-
prevalence in Malawian children less than 14 years old was
estimated to be 2.7%.12 Malaria transmission in rural com-
munities around Blantyre occurs year-round peaking during
the rainy season (NovembereJune).
Children diagnosed with HIV were followed up in
paediatric HIV clinics, received daily preventive co-
trimoxazole and, from 2001 and when eligible, combination
antiretroviral therapy ([ART] lamivudine, stavudine and
nevirapine; Triomune, Cipla). Routine CD4 quantification
and WHO staging were introduced in 2006.Patients
As part of a longstanding clinico-pathological study of CM in
Blantyre,13 Malawian children aged 6-months to 12-years
presenting to QECH with clinical CM were recruited and
managed on a paediatric research facility during consecu-
tive rainy seasons from February, 1996 to June, 2011.Management
Patients with CM were treated with intravenous quinine for
at least 24 h and then switched to oral drugs (Sulphadoxine-
pyrimethamine pre-2007 or Lumefantrine-artemether).
Ward rounds by experienced clinicians were conducted
twice daily.
From 2001 all patients whose HIV status was unknown
were tested for HIV after a parent or legal guardian gave
consent. Prior to 2001 HIV tests were conducted retrospec-
tively on stored samples. In fatal cases where HIV-status
was unknown, it was done posthumously. Ethical approvaluences the inflammatory response but not the outcome of cerebral
16/j.jinf.2016.05.012
Table 1 Summary of publications providing data on the interaction between HIV and cerebral malaria (CM Q9). Q10
First author
and
year of
publication
Participants Study aim # Of cases
with coma*
# Of cases
with HIV
# Of cases with
HIV & coma
Retinal
examination
used to
refine
CM diagnosis
Key findings Findings specific to
HIV and cerebral
malaria
Bronzan
at al, 2007
1388
hospitalised
Malawian
children with
severe
falciparum
malaria
To examine the
association
between HIV,
bacteraemia
and outcome.
1217 179 (16%) 150 (86 coma
only; 64 anaemia
and coma)
No Association
between non-
typhoidal
salmonella
bacteraemia, HIV
infection and
malaria; 2)
HIVþ children
were older than
HIV children
1) HIVþ children
more likely to
have anaemia than
coma as a
complication 2)
Coma occurs in
older children
than anaemia.
Cohen
et al., 2005
336
hospitalised
South African
(Soweto) adults
with falciparum
malaria
To assess the
effect of HIV
infection and CD4
count on the risk
of developing
severe malaria
7 110 (33%) 3 No HIV infection was
associated with a
higher risk of
severe malaria and
death. Risk
compounded by
low CD4 count.
Insufficient
numbers of
comatose
children.
Grimwade
et al., 2004
613 South
African
(KwaZulu-
Natal) adults
with falciparum
malaria
To measure the
association
between HIV
status and
outcome from
malarial infection
32 180 (29.9%) 16 No 1) Increased risk of
severe disease in
HIVþ adults
compared to HIV
; 2) Increased
mortality in
HIVþ cases: 3)
Parasitaemia not
affected by HIV
status.
Higher proportion
of HIVþ cases with
coma. Other
parameters not
examined
separately in
comatose and non-
comatose adults
(as not objective
of study).
Grimwade
et al., 2003
663 South
African
(KwaZulu-
Natal) children
with falciparum
malaria
To describe
associations
among HIV status,
presentation and
outcome from
malaria in children
11 67 (10.1%) 3 No HIV infection
associated with
severe/
complicated
malaria
Trend toward
higher proportion
of HIVþ cases with
coma.
(continued on next page)
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Table 1 (continued )
First author
and
year of
publication
Participants Study aim # Of cases
with coma*
# Of cases
with HIV
# Of cases with
HIV & coma
Retinal
examination
used to
refine
CM diagnosis
Key findings Findings specific to
HIV and cerebral
malaria
Hendricksen
et al., 2012
655
Hospitalised
children (68
adults) with
falciparum
malaria
To determine the
impact of HIV on
clinical signs,
complications, and
disease outcome
of severe malaria
495 children;
48 adults
74 children
(14.9%); 49 adults
(72.1%)
54 children; 35 adults No 1) Higher mortality
and parasite
burden in
HIVþ children 2)
Higher proportion
of HIVþ children
with respiratory
distress/acidosis
3) Higher rate of
clinical
comorbidities
(e.g. pneumonia;
’clinical’ sepsis) in
HIVþ children.
Proportion of
children with
coma not affected
by HIV status.
Other parameters
not examined
separately in
comatose and non-
comatose children
(as not objective
of study).
Niyongabo
et al., 1994
31 Burundian
adults with
cerebral
malaria
To identify risk
factors for poor
prognostic in
cerebral malaria in
adults
31 12 (38.7%) 12 No No clear effect of
HIV-1 infection on
presenting
features of
cerebral malaria
or outcome.
As per key findings
but low numbers
of patients.
Imani et al.,
2011
100 Ugandan
children with
CM compared
with 132
uncomplicated
malaria and
120
aparasitemic
controls
To determine
whether there is
an association
between HIV and
the development
of CM
100 15 overall (4.3%) 9 (9%) No Higher proportion
of children with
CM are
HIVþ compared
with children with
uncomplicated
malaria or no
malaria
As per key
findings. No
specific
information on
subgroup of
comatose
HIVþ children (as
not objective of
study)
Hochmann
et al., 2015
Post-mortem
study of 30
children 15 of
whom were HIV
positive.
Retrospective
review of
children with a
clinical
diagnosis of
CM.
1. To examine the
effect of HIV on
histological
features post-
mortem.
2. To examine the
effect of HIV on
mortality.
2009 232 (11.5%) 232 (11.5%) Yes for post-
mortem
cases
No for
mortality
analysis
1. Greater
platelet,
monocyte and
neutrophils in HIV
positive
2. Higher mortality
in comatose HIV-
infected than
uninfected
children
As per key
findings.
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All patients 
N=2555
CM 
N=1907
No data, HIV status = 250
No data, Retinopathy 
status = 352
CM with known HIV and Retinopathy status = 1305
Retinopathy 
Positive
N=877
(67.2%) 
Retinopathy 
Negative
N=428
(32.8%) 
HIV-infected
N=126
(14.4%) 
HIV-infected
N=59
(13.8%) 
HIV-uninfected
N=369
(86.2%) 
HIV-uninfected
N=751
(85.6%) 
Figure 1 Study profile of the children included.
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Figure 2 Age distribution of children by HIV status. Red
represents HIV negative and black HIV-positive. The heights
of the bars give the proportion of CM in each age group. HIV in-
fected children were older with median age of 48 months, IQR
32e72; HIV negative 33 months IQR 23e50; P < .001.
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testing.
Blood collection and diagnostic tests
Venous blood was collected on admission. Plasma was
stored at 80 C for ELISA tests. A full blood count (Coulter
Counter, BectoneDickinson, New Jersey), blood culture
(BACTEC 9120, BectoneDickinson) and thick and thin blood
smears (Field staining) were performed on all patients. Pe-
ripheral parasite density was calculated using the patients’
individual full blood count. HIV testing was performed with
two rapid tests, Determine (Abbott laboratories, Green
Oaks, IL) and Unigold (Trinity Biotech PLC, Bray, Ireland).
A third test was used to resolve discrepancies (Capillus,
Trinity Biotech). For patients <18-months HIV status was
determined by PCR (Amplicore, Roche, Pleasanton, CA).
Unless contraindicated, a lumbar puncture was performed.
Patients with visibly cloudy CSF were excluded from the
analysis.
ELISA tests
We determined HRP2 levels from stored plasma of a subset
of patients, including all patients admitted in 2009, for a
previous study.14 For patients admitted in 2010 and 2011,
TNF, IL10 and sICAM-1 were determined from stored plasma
using commercial ELISA kits: (R&D, Minneapolis; DY210,
DY217B and DY720).
Statistical analysis
Analysis was performed using Stata software (Version 10.0-
Statacorps, Texas USA). Non-normally distributed contin-
uous variables were compared using a ManneWhitney U test
and summarized using medians and interquartile ranges.
Associations between categorical variables were assessed
using the Fisher’s Exact test. The Cox proportional hazards
model was used to analyse time to death by HIV status and
hazard ratios with 95% confidence intervals (CI) reported.
The relationship between mortality and baseline variables
was assessed using odds ratio (OR). The baseline variables
of interest in this assessment were lactate levels, gender,
HIV status and age. A logistic regression model was fitted
to obtain unadjusted and adjusted OR in this assessment
for the four baseline variables. The OR, associated 95% con-
fidence intervals and the p-values have been reported.
Graphical summaries have also been presented for the vari-
ables of interest. These include Kaplan Meier plots for the
time to event data, histograms and dot plots for summaris-
ing continuous data between groups. All tests were consid-
ered statistically significant at 5% significance level.
Ethics statement
The study was approved by ethics committees of the
College of Medicine, University of Malawi (P.02/10/860),
Michigan State University, USA and Liverpool School of
Tropical Medicine, UK (09.74), of note specific ethical
approval was obtained for retrospective and posthumous
HIV-testing.Please cite this article in press as: Mbale EW, et al., HIV coinfection infl
malaria in Malawian children, J Infect (2016), http://dx.doi.org/10.10Results
Retrospective review by HIV status of all
retinopathy-positive cases prospectively recruited
into the Blantyre clinico-pathological study of CM
Of 2555 children admitted to the paediatric research ward
from 1996 to 2011, 1905 children fulfilled the WHO defini-
tion of CM. Of these 1657 (86.9%) had data on HIV status.
877 children had malarial retinopathy on fundoscopy and
126 (14.4%) of these retinopathy positive children were
HIV-infected (Fig. 1). Data on WHO HIV staging and CD4
counts of patients prior to 2007 were unavailable. Of the
37 HIV-infected retinopathy positive CM cases admitteduences the inflammatory response but not the outcome of cerebral
16/j.jinf.2016.05.012
Table 2 Clinical Characteristics of retinopathy positive and retinopathy negative children included in the study, compared y HIV status.
Variable Retinopathy positive Retinopathy negative
HIV-uninfected (N Z 751) HIV infected (N Z 126) p HIV-uninfected (N Z 28) HIV-infected (N Z 59) p
N Value N Value N Value N Value
Male sex, N (%) 749 47.53% 126 52.38% 0.336 368 50.32% 59 57.14% 0.8056
Age, months (IQR) 751 34 (24e52) 126 49.5 (32e72) <0.0001 369 36 (24e57) 59 49 (26e72) 0.0157
Weight-for-age, z-score (IQR) 749 1.61 (2.37, 0.86) 126 2.08 (2.82, 1.25) 0.0001 351 1.77 (2.59 t 1.00) 59 1.85 (2.66 to 0.97) 0.494
MUAC-for-age, z-score (IQR) 600 1.06 (1.70, 0.44) 74 1.41 (2.28, 0.72) 0.014 274 1.22 (1.88 t 0.42) 30 1.37 (2.40 to 0.20) 0.437
Fever duration at admission,
hrs (IQR)
728 48 (36e72) 122 48 (24e72) 0.7858 297 48 (24e72) 59 37 (16e72) 0.89
Duration of coma at admission,
hrs (IQR)
624 6 (3e12) 104 6 (3.5e15) 0.8891 369 5 (3e9) 59 4 (2e7) 0.68
History of convulsions, N (%) 671 482 (71.83%) 119 78 (65.55%) 0.189 296 85.67% 48 79.59% 0.811
History of antimalarials (%)a 679 197 (29.01%) 118 35 (29.66%) 0.913 369 110 (29.81%) 59 17 (28.81%) 0.876
Temp, C (IQR) 751 38.7 (37.9e39.5) 126 38.7 (38.0e39.8) 0.1533 369 38.7 (37.6e39. 49 38.9 (37.7e39.8) 0.5302
Pulse rate, per min (IQR) 750 154 (140e171) 126 160 (136e171) 0.6597 369 152 (134e168) 49 148 (134e160) 0.1126
Respiratory rate, per min (IQR) 750 44 (38e54) 126 48 (36e58) 0.3081 369 42 (36e54) 49 44 (32e56) 0.8453
Systolic BP, mmHg (IQR) 729 100 (91e110) 122 100 (90e114) 0.8616 369 104 (95e120) 49 104 (90e119) 0.4854
Abnormal chest findings, N (%) 746 53 (7.10%) 122 17 (13.93%) 0.018 253 6.72% 23 9.30% 0.72
Lymphadenopathy, N (%) 327 12 (3.67%) 46 4 (8.7%) 0.121 102 6.86% 11 27.27% 0.057
Jaundice, N (%) 325 26 (8.00%) 46 4 (8.70%) 0.456 102 1.96% 4 9.09% 0.267
NZ Number, IQRZ Interquartile range, MUAC Z Mid upper arm circumference, WBCZWhite blood cell count, BP Z blood pressur min Z minute, hrs Z hours.
a Antimalarials taken included Chloroquine, SP, quinine, LA.
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YJINF3750_proof ■ 16 June 2016 ■ 7/11after 2007, WHO staging was available for 19; 10 were WHO
stage I, 1 was stage II, 4 in stage III and 4 stage IV. Two chil-
dren were on ART at the time of admission.
As shown in Fig. 2, compared with HIV-uninfected chil-
dren HIV-infected children with retinopathy positive CM
were older (HIV-infected 49.5 months, IQR 32.0e72.0;
HIV-uninfected patients 34 months, IQR 24.0e52.0,
p < 0.001). HIV-infected children were also more likely to
have evidence of co-morbidities, specifically abnormal
chest auscultation findings (crackles, wheeze: HIV-
infected 13.9%, HIV-uninfected 7.1%; p Z 0.018; Table 2)
and poor nutritional status: lower weight-for-age z-scores
(HIV-infected median 2.08, IQR 2.82 to 1.25; HIV-
uninfected 1.61, IQR-2.37 to 0.86, pZ 0.001) and lower
median mid upper arm circumference-for-age z-score,
(HIV-infected 1.29, IQR 2.07 to 0.67; uninfected
1.06, IQR 1.67 to 0.37; p Z 0.014).
Other key symptomatic features of illness prior to
presentation to hospital including vital observations (respi-
ratory rate, pulse, blood pressure) and the duration of
presenting features (fever, convulsions, coma) were similar
between HIV-infected and uninfected children (Table 2).
The number of children who had received either oral or
parenteral antimalarial treatment (chloroquine, sulphadox-
ine pyrimethamine, lumefantrine-artemether or quinine)
before arrival at QECH was also not affected by HIV status
(HIV-infected, 29.7%, HIV-uninfected, 29.0%, p Z 0.91).
Characteristics of retinopathy negative cases are discussed
below.
Baseline laboratory findings on admission
Geometric mean peripheral parasite densities were similar
between HIV-infected (45,059 parasites/ml, 95% CI
28,098e72,258) and HIV-uninfected children (40,195 para-
sites/ml, 95% CI 32,771e49,301 pZ 0.68, Table 3), as were
geometric mean HRP2 concentrations between the subset
of 139 HIV-uninfected (1268 ng/ml, 95% CI 1002e1604)
and 24 HIV-infected children (946 ng/ml, 95% CI
393e2279; p Z 0.39; Table 3 and Fig. 3) in whom HRP2
levels were measured. The geometric mean and 95% CI
for peripheral parasite density of this subset in whom
HRP2 was measured was similar to the overall cohort, sug-
gesting it was representative of the cohort as a whole
(Fig. 4). Other laboratory parameters were similar between
HIV-infected and HIV-uninfected children (Table 3). Labora-
tory characteristics of retinopathy negative cases are dis-
cussed below.
Disease progression and outcome
It took HIV-infected children with retinopathy positive CM
longer to fully recover consciousness (coma resolution
time: HIV infected, median 42.0 h, IQR 22.0e70.0; HIV-
uninfected children, median 34.0 h, IQR 18.0e56.0;
p Z 0.0085, Supplemental Table 1). However parasite
clearance time, (the time in hours from admission until
two consecutive thick smears were negative) was similar
in HIV-infected (42.0 h, IQR 30.0e54.0 h) and uninfected
children (42 h, IQR 28.0e54.0 h; p Z 0.628) as was time
to fever clearance (the time in hours from admission untiluences the inflammatory response but not the outcome of cerebral
16/j.jinf.2016.05.012
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Figure 3 Similar peripheral parasite density and HRP2
levels in HIV-infected HIV-uninfected children with retinop-
athy positive CM. Horizontal lines represent medians and
bars represent interquartile range. There was no difference
in either: (A) peripheral parasitaemia or (B) HRP2 levels be-
tween the two groups, p values 0.88 and 0.78, respectively. Pe-
ripheral parasite density in the subset of HIV-positive and HIV-
negative patients who had HRP2 measured was similar to para-
site density in their respective groups in the study overall.
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YJINF3750_proof ■ 16 June 2016 ■ 8/11the last recorded temperature >37.5 C; IQR 20.0e74.0 and
20.0e54.0; p Z 0.0689).
The unadjusted hazard ratio for fatal outcome was not
significant (HIV-infected 24.8%, HIV-uninfected 18.5%; Haz-
ard ratio 1.104; 95% CI 0.645e1.887; p Z 0.13). Among
retinopathy positive children this remained non-significant
when analysis was restricted to children <5 years old
(27.2% and 18.1%; p Z 0.07) or children <3 years old (25%
and 12.8%; p Z 0.08). There was also no difference in
survival profile between the HIV-infected and uninfected
children (p Z 0.720, Supplemental Fig. 1).
In view of significant changes to the management of HIV
and malaria (e.g. the roll out of ART for HIV in 2007 and
lumefantrine-artemether for uncomplicated malaria in
2012) and progression of the HIV epidemic in Malawi,12,15
we analysed the data in five-year periods (1996e2000;
2001e2005; 2006e2011), looking at patient characteristics,
clinical course and mortality (Supplementary Table 2). Each
period gave similar results to the overall cohort.
Within a logistic regression model adjusting for age (in
months) and sex, among the retinopathy positive children,
lactate was the only independent predictor of mortality
(OR 1.10 per mmol increase, 95% CI 1.04e1.16, p < 0.001;
Supplemental Tables 2 and 3).
Retinopathy negative cases
In the retrospective review of patients admitted
1996e2011, 428 children were retinopathy negative and
of these 59 children (13.8%) were HIV-infected (Fig. 2). As
with retinopathy positive cases HIV-infected retinopathy
negative cases were also older than HIV-uninfected cases
(Table 2). However in contrast to retinopathy positivePlease cite this article in press as: Mbale EW, et al., HIV coinfection infl
malaria in Malawian children, J Infect (2016), http://dx.doi.org/10.10cases, HIV-infected children had differences compared to
HIV-uninfected children in a number of laboratory indices.
HIV-infected retinopathy negative children had a higher
parasitaemia geometric mean parasite density (74,416 par-
asites/ml; 95% CI 49,648e111,541) than HIV-uninfected chil-
dren (34,191 parasites/ml; 95% CI 27,137e43,078,
p Z 0.010, Table 3). Geometric mean HRP2 level was also
higher in HIV-infected children (214 ng/ml, 95% CI
99.5e459) compared with HIV-uninfected children
(86.3 ng/ml, 95% CI 58.3e128), although not statistically
significant (p Z 0.19). Consistent with previous data14
HRP2 levels were significantly lower in retinopathy negative
than in retinopathy positive CM cases (p < 0.001). Median
haematocrit (HIV infected 27%, IQR 20e30%; HIV uninfected
29%, IQR 25e33%; p Z 0.0014) and median platelet levels
(HIV infected 78  109/L, IQR 34e178  109/L; HIV unin-
fected 148  109/L, IQR 61e225  109/L; p Z 0.0047)
were significantly lower in HIV-infected children. Other
clinical features were not significantly different between
HIV-infected and uninfected retinopathy negative children
(Table 2) and there was not a significant effect of HIV-
status on mortality (HIV-infected 13.8%, HIV-infected
9.81%; Hazard ratio 1.47; 95% CI 0.55e3.46; p Z 0.36).
Taken together, comparison of the effect of HIV on CM
cases by retinal status indicates that HIV status has a larger
effect on clinical features among retinopathy negative
cases than among retinopathy positive cases.
Plasma cytokine levels in HIV-infected and
uninfected retinopathy positive CM patients
In total, 224 children with a clinical diagnosis of CM were
admitted in 2010 and 2011. Of these, 153 children had
retinopathy positive CM and had data available on HIV
status: 137 were HIV-uninfected and 15 HIV-infected.
Plasma for cytokine analyses was missing or insufficient in
18 cases: 15 HIV-uninfected and 3 HIV-infected.
TNF levels on admission in the 12 HIV-infected children
(median 6.47 pg/mL; IQR 4.92 pg/mL to 13.4 pg/mL) were
markedly lower than in the 122 HIV-uninfected children
(median 39.3 pg/mL; IQR 16.1 pg/mL to 82.6 pg/mL;
p Z 0.0079; Fig. 4A). IL10 levels were also significantly
lower in the HIV-infected (median 0.43 ng/mL; IQR
0.27 ng/mL to 0.96 ng/mL) compared to HIV-uninfected
children (median 1.01 ng/mL; IQR 0.49 ng/mL to 2.96 ng/
mL; p Z 0.045; Fig. 4B). The TNF-to-IL10 ratio was not
significantly affected by HIV status (HIV-uninfected, me-
dian 33.4; IQR 13.3 to 74.1; HIV-infected, median 16.1;
IQR 6.39 to 56.5; Fig. 4C).
Sufficient plasma was available to measure sICAM-1 for
107 HIV-uninfected and 12 HIV-infected retinopathy posi-
tive children. sICAM-1 levels were significantly lower in the
HIV-infected (median 350 ng/mL; IQR 289e437 ng/mL) than
in the HIV-uninfected children (median 563 ng/mL; IQR
330e841 ng/mL; p Z 0.04; Fig. 4D).
Discussion
We have used a large cohort of well-characterized patients
and a stringent definition of CM to explore the effect of HIV
on CM in an attempt to unravel the controversy relating touences the inflammatory response but not the outcome of cerebral
16/j.jinf.2016.05.012
Figure 4 Soluble plasma markers in HIV-infected and HIV-uninfected children with CM. Median admission plasma levels
measured by ELISA of TNF, ICAM-1 and IL10 in HIV-positive children were significantly lower than those of HIV negative children.
(A, B, C) however the ratio of TNF to IL10 (D) was similar in the two groups. Horizontal lines represent medians and bars represent
interquartile range.
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YJINF3750_proof ■ 16 June 2016 ■ 9/11the role of systemic inflammation in CM pathogenesis. HIV
had a marked effect on the inflammatory response to CM:
HIV-uninfected children with CM had substantially raised
TNF and ICAM-1 levels compared to HIV-infected CM
children. IL-10 levels were also lower in HIV-infected
children but the TNF-to-IL-10 ratio remained similar, hence
there was not a clear pro/anti-inflammatory cytokine
imbalance. Despite this marked blunting of the inflamma-
tory response, HIV-infected and uninfected children with
retinopathy positive CM had a similar outcome.
It is likely that the lack of systemic inflammatory
response in HIV-positive children is at least in part due to
impaired CD4 T-cell function. Peripheral blood mononu-
clear cells from HIV-infected adults have decreased TNF
production (T-helper 1 cytokine) in response to challenge
with P. falciparum in vitro.11 Therefore through abrogating
the cytokine response to malaria infection in HIV infected
individuals, HIV has provided a ‘natural experiment’, shed-
ding light on the role of the systemic cytokine response in
CM pathogenesis. With regards to the pro-inflammatory T-
helper 1 response, it has been long postulated that pro-
inflammatory cytokines, particularly TNF, may provide a
double-edged sword in malaria outcome. On the one
hand, TNF may play a critical role in the immune controlPlease cite this article in press as: Mbale EW, et al., HIV coinfection infl
malaria in Malawian children, J Infect (2016), http://dx.doi.org/10.10of overall parasite burden which may be an important
determinant of disease severity and outcome.16 On the
other hand, high levels of TNF and a cytokine storm have
been postulated to be critical in the development and
outcome of severe and CM.16,17 Here we show that HIV-
infected children have retinopathy positive CM with similar
clinical features, peripheral parasite density, HRP2 levels
and outcome, despite a markedly blunted cytokine
response, to HIV-uninfected children with retinopathy-
positive CM. These findings imply that substantially raised
systemic TNF levels and a cytokine storm are not necessary
for the development of CM. Hochman et al. found a higher
level of platelet and monocyte accumulation in histologic
sections of cerebral vessels in HIV-infected cases in associ-
ation with sites of iRBC sequestration compared to HIV-
uninfected cases.18 Given the localised nature of these pa-
thologies and given our data indicating a lack of significant
systemic inflammation in HIV-infected children, these his-
topathological findings suggest that specific interactions
between iRBC and either the endothelium itself or other
host cells in close proximity may be important in disease
pathogenesis.
Examining the genes expressed by iRBC sequestered in
the brain, Tembo et al. demonstrated that different varuences the inflammatory response but not the outcome of cerebral
16/j.jinf.2016.05.012
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YJINF3750_proof ■ 16 June 2016 ■ 10/11genes were expressed between HIV-infected and HIV-
uninfected children.19 Var genes control the surface pro-
teins expressed on iRBC and thereby the host endothelial
receptors with which they bind and interact. Taken
together these findings indicate that the local histological
differences observed by Hochman and colleagues between
HIV-infected and uninfected children may reflect differ-
ences in the nature of the iRBC-endothelial interaction.
What factors lead to different var gene expression in HIV
and how this affects the iRBC-host cell interaction remains
to be determined but elucidating this may shed further
light on CM pathogenesis in both HIV-infected and unin-
fected children.
The lack of a significant difference in mortality rate
between HIV-infected and uninfected CM cases here seem
to contradict a recent publication that found a higher mor-
tality in HIV-infected children admitted to our facility.18
The principal difference between the analyses is that the
earlier publication used a purely clinical definition of CM
whereas we used retinopathy status to improve specificity
and hence only include cases for which coma is more likely
to be caused by malaria.18 By including all cases, whether
true retinopathy positive CM or not, the earlier study had
a slightly larger sample size and we cannot exclude that
this may have increased the statistical power to detect a
significant mortality difference. However it is also possible
that the mortality difference associated with HIV in the
earlier analysis is unrelated to any effect of HIV on CM
but instead due to confounding factors e in particular
that HIV is highly associated with death from other comor-
bidities, such as bacterial infection. The effect of such con-
founders is likely to be stronger in an analysis that, due to
lack of diagnostic specificity, includes a significant propor-
tion of children whose coma is not caused by malaria.
Different specificities of the clinical case definitions and
different rates of co-morbidities may also be important in
explaining different and apparently inconsistent effects of
HIV on mortality reported in previous severe malaria
studies.
Although our data are derived from a large cohort of CM
patients, our study was limited by the relatively small
number and small volume of plasma samples available. We
were therefore only able to measure one Th1 and one Th2
cytokine on presentation to hospital. Serial blood samples
may have provided a more complete picture. We also did
not undertake long-term follow up to reliably determine
whether HIV affects the risk of subtle or slowly developing
neurodevelopmental sequelae following CM.
In conclusion, when CM is defined precisely in African
children, HIV has a marked impact on the cytokine response
but little effect on either parasite density or the clinical
course of CM. Taken with other recent studies these data
point towards local iRBC-associated effects rather than
systemic inflammation as the primary driver of pathogen-
esis in human CM.118
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